432 related articles for article (PubMed ID: 11927628)
1. A natural killer T (NKT) cell developmental pathway iInvolving a thymus-dependent NK1.1(-)CD4(+) CD1d-dependent precursor stage.
Pellicci DG; Hammond KJ; Uldrich AP; Baxter AG; Smyth MJ; Godfrey DI
J Exp Med; 2002 Apr; 195(7):835-44. PubMed ID: 11927628
[TBL] [Abstract][Full Text] [Related]
2. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen.
Hameg A; Apostolou I; Leite-De-Moraes M; Gombert JM; Garcia C; Koezuka Y; Bach JF; Herbelin A
J Immunol; 2000 Nov; 165(9):4917-26. PubMed ID: 11046017
[TBL] [Abstract][Full Text] [Related]
3. CD1d-restricted NKT cells: an interstrain comparison.
Hammond KJ; Pellicci DG; Poulton LD; Naidenko OV; Scalzo AA; Baxter AG; Godfrey DI
J Immunol; 2001 Aug; 167(3):1164-73. PubMed ID: 11466330
[TBL] [Abstract][Full Text] [Related]
4. CD1d-specific NK1.1+ T cells with a transgenic variant TCR.
Sköld M; Faizunnessa NN; Wang CR; Cardell S
J Immunol; 2000 Jul; 165(1):168-74. PubMed ID: 10861049
[TBL] [Abstract][Full Text] [Related]
5. Natural killer T-cell populations in C57BL/6 and NK1.1 congenic BALB.NK mice-a novel thymic subset defined in BALB.NK mice.
Stenström M; Sköld M; Andersson A; Cardell SL
Immunology; 2005 Mar; 114(3):336-45. PubMed ID: 15720435
[TBL] [Abstract][Full Text] [Related]
6. Resistance to malarial infection is achieved by the cooperation of NK1.1(+) and NK1.1(-) subsets of intermediate TCR cells which are constituents of innate immunity.
Mannoor MK; Weerasinghe A; Halder RC; Reza S; Morshed M; Ariyasinghe A; Watanabe H; Sekikawa H; Abo T
Cell Immunol; 2001 Aug; 211(2):96-104. PubMed ID: 11591113
[TBL] [Abstract][Full Text] [Related]
7. Control of NKT cell differentiation by tissue-specific microenvironments.
Yang Y; Ueno A; Bao M; Wang Z; Im JS; Porcelli S; Yoon JW
J Immunol; 2003 Dec; 171(11):5913-20. PubMed ID: 14634102
[TBL] [Abstract][Full Text] [Related]
8. NK1.1+ T cells in the liver arise in the thymus and are selected by interactions with class I molecules on CD4+CD8+ cells.
Coles MC; Raulet DH
J Immunol; 2000 Mar; 164(5):2412-8. PubMed ID: 10679077
[TBL] [Abstract][Full Text] [Related]
9. Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells.
Eberl G; Lees R; Smiley ST; Taniguchi M; Grusby MJ; MacDonald HR
J Immunol; 1999 Jun; 162(11):6410-9. PubMed ID: 10352254
[TBL] [Abstract][Full Text] [Related]
10. DX5/CD49b-positive T cells are not synonymous with CD1d-dependent NKT cells.
Pellicci DG; Hammond KJ; Coquet J; Kyparissoudis K; Brooks AG; Kedzierska K; Keating R; Turner S; Berzins S; Smyth MJ; Godfrey DI
J Immunol; 2005 Oct; 175(7):4416-25. PubMed ID: 16177083
[TBL] [Abstract][Full Text] [Related]
11. Immediate antigen-specific effector functions by TCR-transgenic CD8+ NKT cells.
Wingender G; Berg M; Jüngerkes F; Diehl L; Sullivan BA; Kronenberg M; Limmer A; Knolle PA
Eur J Immunol; 2006 Mar; 36(3):570-82. PubMed ID: 16506291
[TBL] [Abstract][Full Text] [Related]
12. CD1d-independent developmental acquisition of prompt IL-4 gene inducibility in thymus CD161(NK1)-CD44lowCD4+CD8- T cells is associated with complementarity determining region 3-diverse and biased Vbeta2/Vbeta7/Vbeta8/Valpha3.2 T cell receptor usage.
Chen YT; Kung JT
J Immunol; 2005 Nov; 175(10):6537-50. PubMed ID: 16272308
[TBL] [Abstract][Full Text] [Related]
13. Role of the complementarity-determining region 3 (CDR3) of the TCR-beta chains associated with the V alpha 14 semi-invariant TCR alpha-chain in the selection of CD4+ NK T Cells.
Ronet C; Mempel M; Thieblemont N; Lehuen A; Kourilsky P; Gachelin G
J Immunol; 2001 Feb; 166(3):1755-62. PubMed ID: 11160221
[TBL] [Abstract][Full Text] [Related]
14. The adaptor protein AP-3 is required for CD1d-mediated antigen presentation of glycosphingolipids and development of Valpha14i NKT cells.
Elewaut D; Lawton AP; Nagarajan NA; Maverakis E; Khurana A; Honing S; Benedict CA; Sercarz E; Bakke O; Kronenberg M; Prigozy TI
J Exp Med; 2003 Oct; 198(8):1133-46. PubMed ID: 14557411
[TBL] [Abstract][Full Text] [Related]
15. DOCK2 is required in T cell precursors for development of Valpha14 NK T cells.
Kunisaki Y; Tanaka Y; Sanui T; Inayoshi A; Noda M; Nakayama T; Harada M; Taniguchi M; Sasazuki T; Fukui Y
J Immunol; 2006 Apr; 176(8):4640-5. PubMed ID: 16585555
[TBL] [Abstract][Full Text] [Related]
16. Expression of CD1d under the control of a MHC class Ia promoter skews the development of NKT cells, but not CD8+ T cells.
Xu H; Chun T; Colmone A; Nguyen H; Wang CR
J Immunol; 2003 Oct; 171(8):4105-12. PubMed ID: 14530332
[TBL] [Abstract][Full Text] [Related]
17. Defining a novel subset of CD1d-dependent type II natural killer T cells using natural killer cell-associated markers.
Singh AK; Rhost S; Löfbom L; Cardell SL
Scand J Immunol; 2019 Sep; 90(3):e12794. PubMed ID: 31141185
[TBL] [Abstract][Full Text] [Related]
18. Type I IFN-producing CD4 Valpha14i NKT cells facilitate priming of IL-10-producing CD8 T cells by hepatocytes.
Wahl C; Bochtler P; Schirmbeck R; Reimann J
J Immunol; 2007 Feb; 178(4):2083-93. PubMed ID: 17277112
[TBL] [Abstract][Full Text] [Related]
19. NKT cells are phenotypically and functionally diverse.
Hammond KJ; Pelikan SB; Crowe NY; Randle-Barrett E; Nakayama T; Taniguchi M; Smyth MJ; van Driel IR; Scollay R; Baxter AG; Godfrey DI
Eur J Immunol; 1999 Nov; 29(11):3768-81. PubMed ID: 10556834
[TBL] [Abstract][Full Text] [Related]
20. Quantitation and phenotypic analysis of natural killer T cells in primary biliary cirrhosis using a human CD1d tetramer.
Kita H; Naidenko OV; Kronenberg M; Ansari AA; Rogers P; He XS; Koning F; Mikayama T; Van De Water J; Coppel RL; Kaplan M; Gershwin ME
Gastroenterology; 2002 Oct; 123(4):1031-43. PubMed ID: 12360465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
